Minerva Respiratory Medicine

Aims & Scope

The main topics of the journal are related to pathophysiology, pharmacology, interventional pulmonology, non-invasive ventilation and intensive care in respiratory diseases, obstructive, restrictive and rare lung diseases, pulmonary oncology, pulmonary hypertension, infectious and immunologic diseases, thoracic surgery and lung transplantation.

The aim of the journal is to influence the practice of clinicians, researchers and industries at an international level and provide its readers with papers of the highest quality thanks to a fast and thorough peer review process, careful editorial work as well as open access options.

Minerva Respiratory Medicine welcomes articles on a wide variety of topics related to Diseases of the Respiratory System, which may be submitted in the form of editorials, original articles, review articles, special articles, letters to the Editor and guidelines.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	0.1
2024	0.20

SJR (SCImago Journal Rank)

Year	Value
2024	0.123

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	10

Journal Rank

Year	Value
2024	27065

Journal Citation Indicator

Year	Value
2024	15

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The Systemic Inflammation Index on admission is independently associated with length of stay in hospitalized COVID-19 patients

  Citation: 13

  Authors: Angelo, Valentina, Elena, Giacomo, Luigi A., Ciriaco, Pietro, Sergio, Arduino A., Alessandro G.

• PD-L1 as a prognostic and predictive biomarker in neuroendocrine tumors of the lung: state of the art and future perspectives

  Citation: 4

  Authors: Francesca, Magda, Stefano, Maurizio, Simona, Alessandra, Alfonso, Giorgia, Nicla, Francesco, Domenico

• Diagnostic value of LunX mRNA and CEA mRNA expression in pleural fluid of patients with non-small cell lung cancer

  Citation: 4

  Authors: Khatereh, Naghmeh, Mohammad, Behrooz, Tahereh, Maral, Abdolreza

• COVID-19 induced immunosuppression leading to secondary infection in a non-HIV patient

  Citation: 4

  Authors: Tran T., Vinh, Le Q., Tiffany, Akshay, Sedighe, Le H., Le H., Tuyet T., Nguyen T., Frank, Pham N., Nguyen

• Neurological manifestations in COVID-19: an overview

  Citation: 4

  Authors: Zeinab, Arefeh, Ali, Mousa, Mostafa, VeneelaKrishna R., Hajar, Soheil

• Investigating gene expression level of MUC1 and CEA in pleural fluid of NSCLC lung cancer patients with real-time RT-PCR method

  Citation: 4

  Authors: Sara, Naghmeh, Kazem, Mahya, Fahimeh, Mehdi, Abdolreza

• Modelling hospital bed necessity for COVID-19 patients during the decline phase of the epidemic trajectory

  Citation: 4

  Authors: Eyal, Chiara, Lorenza, Mattia, Andrea, Paola, Luigia, Andrea, Pier P., Mario

• Sequelae of traumatic rib fractures: management in the Emergency Department

  Citation: 3

  Authors: Francesco, Filippo, Matteo, Nello, Mattia, Ottavio, Piero E., Gian C., Luigi M.

• Late-onset pneumothorax as a complication of COVID-19 disease

  Citation: 3

  Authors: Floriana, Emanuele

• Clinical features and long-term prognostic outcomes in patients with hemoptysis related to upper respiratory airways diseases: a prospective, Italian, multicenter study

  Citation: 3

  Authors: Michele, Paolo, Rocco, Giuseppe, Nicolò, Alessandro, Pietro, Stefano, Martina, Silvia, Andrea, Laura, Beatrice, Fausta, Paolo, Stefano, Giovanni

---